BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 35456461)

  • 1. Identification of Potential Key Genes in Prostate Cancer with Gene Expression, Pivotal Pathways and Regulatory Networks Analysis Using Integrated Bioinformatics Methods.
    Khan MM; Mohsen MT; Malik MZ; Bagabir SA; Alkhanani MF; Haque S; Serajuddin M; Bharadwaj M
    Genes (Basel); 2022 Apr; 13(4):. PubMed ID: 35456461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocrine Disrupting Chemicals Influence Hub Genes Associated with Aggressive Prostate Cancer.
    Alwadi D; Felty Q; Yoo C; Roy D; Deoraj A
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction and analysis of mRNA, miRNA, lncRNA, and TF regulatory networks reveal the key genes associated with prostate cancer.
    Ye Y; Li SL; Wang SY
    PLoS One; 2018; 13(8):e0198055. PubMed ID: 30138363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Potential miRNAs Biomarkers for High-Grade Prostate Cancer by Integrated Bioinformatics Analysis.
    Foj L; Filella X
    Pathol Oncol Res; 2019 Oct; 25(4):1445-1456. PubMed ID: 30367364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of key genes in prostate cancer gene expression profile by bioinformatics.
    Lu W; Ding Z
    Andrologia; 2019 Feb; 51(1):e13169. PubMed ID: 30311263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of key genes and pathways in castrate-resistant prostate cancer by integrated bioinformatics analysis.
    Wu YP; Ke ZB; Lin F; Wen YA; Chen S; Li XD; Chen SH; Sun XL; Huang JB; Zheng QS; Xue XY; Wei Y; Xu N
    Pathol Res Pract; 2020 Oct; 216(10):153109. PubMed ID: 32853947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bioinformatics-based identification of the key genes associated with prostate cancer].
    Zhao HB; Xu GB; Yang WQ; Li XZ; Chen SX; Gan Y; Su ZM; Sheng M; Zeng YR
    Zhonghua Nan Ke Xue; 2021 Jun; 27(6):489-498. PubMed ID: 34914287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of Potential Gene Expression and Regulation Networks in Prostate Cancer Using Bioinformatics Tools.
    Liu H; Li L; Fan Y; Lu Y; Zhu C; Xia W
    Oxid Med Cell Longev; 2021; 2021():8846951. PubMed ID: 34512870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Identification of Key Gene Expression Signature in Prostate Cancer.
    Huang Y; Cao Q; Song Z; Ruan H; Wang K; Chen K; Zhang X
    Crit Rev Eukaryot Gene Expr; 2020; 30(2):153-168. PubMed ID: 32558494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the Key MicroRNAs and the miRNA-mRNA Regulatory Pathways in Prostate Cancer by Bioinformatics Methods.
    Li D; Hao X; Song Y
    Biomed Res Int; 2018; 2018():6204128. PubMed ID: 30027097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of novel genes associated with a poor prognosis in pancreatic ductal adenocarcinoma via a bioinformatics analysis.
    Zhou J; Hui X; Mao Y; Fan L
    Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31311829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of prostate cancer hub genes and therapeutic agents using bioinformatics approach.
    Fang E; Zhang X; Wang Q; Wang D
    Cancer Biomark; 2017 Dec; 20(4):553-561. PubMed ID: 28800317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioinformatics analysis identified hub genes in prostate cancer tumorigenesis and metastasis.
    Gu P; Yang D; Zhu J; Zhang M; He X
    Math Biosci Eng; 2021 Apr; 18(4):3180-3196. PubMed ID: 34198380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of key microRNAs and hub genes in non-small-cell lung cancer using integrative bioinformatics and functional analyses.
    Song F; Xuan Z; Yang X; Ye X; Pan Z; Fang Q
    J Cell Biochem; 2020 Mar; 121(3):2690-2703. PubMed ID: 31692035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of UBE2C as hub gene in driving prostate cancer by integrated bioinformatics analysis.
    Wang Y; Wang J; Tang Q; Ren G
    PLoS One; 2021; 16(2):e0247827. PubMed ID: 33630978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Potential Key Genes and Pathways in Enzalutamide-Resistant Prostate Cancer Cell Lines: A Bioinformatics Analysis with Data from the Gene Expression Omnibus (GEO) Database.
    Zheng L; Dou X; Ma X; Qu W; Tang X
    Biomed Res Int; 2020; 2020():8341097. PubMed ID: 32724813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analyzing the LncRNA, miRNA, and mRNA Regulatory Network in Prostate Cancer with Bioinformatics Software.
    He JH; Han ZP; Zou MX; Wang L; Lv YB; Zhou JB; Cao MR; Li YG
    J Comput Biol; 2018 Feb; 25(2):146-157. PubMed ID: 28836827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of miR-452-5p in the tumorigenesis of prostate cancer: A study based on the Cancer Genome Atl(TCGA), Gene Expression Omnibus (GEO), and bioinformatics analysis.
    Gao L; Zhang LJ; Li SH; Wei LL; Luo B; He RQ; Xia S
    Pathol Res Pract; 2018 May; 214(5):732-749. PubMed ID: 29559248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of key genes and pathways of thyroid cancer by integrated bioinformatics analysis.
    Liu L; He C; Zhou Q; Wang G; Lv Z; Liu J
    J Cell Physiol; 2019 Dec; 234(12):23647-23657. PubMed ID: 31169306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-93-5p may be an important oncogene in prostate cancer by bioinformatics analysis.
    Yang Y; Jia B; Zhao X; Wang Y; Ye W
    J Cell Biochem; 2019 Jun; 120(6):10463-10483. PubMed ID: 30582208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.